NCT02714829View on ClinicalTrials.gov

Clinical Study of Injectable Ceramics Bone Graft Substitute Containing rhBMP-2

NACompletedINTERVENTIONAL
Enrollment

88

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

September 30, 2017

Study Completion Date

April 30, 2018

Conditions
Alveolar Bone PreservationBone Graft
Interventions
DEVICE

Inject BMP

Injection of ExcelOS-inject(beta-TCP) containing rhBMP-2.

DEVICE

ExcelOS-inject

Injection of ExcelOS-inject(beta-TCP) without rhBMP-2.

Sponsors

Lead Sponsor

BioAlpha Inc.
All Listed Sponsors
lead

BioAlpha Inc.

INDUSTRY

NCT02714829 - Clinical Study of Injectable Ceramics Bone Graft Substitute Containing rhBMP-2 | Biotech Hunter | Biotech Hunter